Eliana Clark Net Worth & Insider Trades

Eliana Clark - EVP, Intellia Therapeutics, Inc

As of July 6, 2023

What is Eliana Clark's Net Worth?

The current estimated net worth of Intellia Therapeutics, Inc's EVP, Eliana Clark, is estimated to be about $1.04M . Eliana Clark owns about 45,146 units of Intellia Therapeutics, Inc common stock. In the last year at Intellia Therapeutics, Inc, Eliana Clark has sold an estimated value of $315.94K worth.

What is Eliana Clark's Past Insider Trading?

Eliana Clark's largest purchase order was 5,000 units , worth over $61.35K on June 22, 2023. Eliana Clark's largest sale order was 5,000 units , worth over $225K on June 22, 2023. In total, Eliana Clark has made about 5 transactions over a year of their time at Intellia Therapeutics, Inc. Eliana Clark usually trades in March, with the busiest year in 2023. The most recent transaction was a sale order of 360 units , worth over $14.58K on July 6, 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Price per Share
Filing Date
No matching records found


Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Eliana Clark's' Mailing Address?

  • Mailing address is C/o Intellia Therapeutics, Inc. 40 Erie Street, Suite 130 Cambridge MA 02139 MA

Intellia Therapeutics, Inc Executive Compensation

Option Awards
Stock Awards
Other Compensation
John M. Leonard, M.D. 2020 $580,000 $319,000 $2,722,890 - $13,786 $3,635,676
John M. Leonard, M.D. 2019 $559,200 $307,560 - - $37,026 $903,786
John M. Leonard, M.D. 2018 $550,000 $302,500 $7,818,005 $1,011,713 $26,112 $9,708,330
Glenn G. Goddard 2020 $407,000 $146,520 $1,001,063 - $8,928 $1,563,511
Glenn G. Goddard 2019 $383,000 $153,200 - - $5,644 $541,844
Glenn G. Goddard 2018 $67,718 $51,652 $1,896,825 - $218 $2,016,413
David Lebwohl, M.D. 2020 $298,378 $228,000 $1,549,720 - $2,690 $2,078,788
Andrew D. Schiermeier, Ph.D. 2020 $455,400 $173,052 $1,081,148 - $8,928 $1,718,528
Andrew D. Schiermeier, Ph.D. 2019 $440,000 $167,200 $611,897 - $8,778 $1,227,875
Andrew D. Schiermeier, Ph.D. 2018 $408,934 $182,600 $2,028,554 $295,550 $9,668 $2,925,306
Laura Sepp-Lorenzino, Ph.D. 2020 $420,000 $184,800 $1,081,148 - $4,578 $1,690,526
Laura Sepp-Lorenzino, Ph.D. 2019 $239,487 $204,086 $1,318,695 - $221 $1,762,489
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1652130/000156459021021413/ntla-def14a_20210623.htm

What are Intellia Therapeutics, Inc's Past Insider Trades?

Intellia Therapeutics, Inc's most recent insider trade came on August 2, 2023 by Muna Bhanji who sold 265 units worth $11.22K . In the last 7 years, insiders at Intellia Therapeutics, Inc have sold an estimated value of $307.39M and bought an estimated value of $44.06M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are John Leonard, President and CEO,  Francois Jean Formela, Director,  and Jose Rivera, EVP .

Intellia Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Price per Share
Filing Date
No matching records found